<?xml version="1.0" ?>
<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Richard H. Carmona, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Dominic J. Caruso</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: W. Roy Dunbar</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Deborah Dunsire, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: James H. Hinton</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Donald R. Knauss</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Bradley E. Lerman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Maria N. Martinez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Kevin M. Ozan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Brian S. Tyler</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Election of eleven directors for a one-year term: Kathleen Wilson-Thompson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Ratification of Appointment of Deloitte &amp; Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2025</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Advisory vote on Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Approve Amendment to Certificate of Incorporation to Provide for Officer Exculpation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Shareholder Proposal on Independent Board Chairman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>McKesson Corporation</issuerName>
    <cusip>58155Q103</cusip>
    <isin>US58155Q1031</isin>
    <meetingDate>07/31/2024</meetingDate>
    <voteDescription>Shareholder Proposal on Report on Risks of State Policies Restricting Reproductive Health Care</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>25638.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>25638.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Dr. Esther M. Alegria</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Richard C. Breeden</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Daniel A. Carestio</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Cynthia L. Feldmann</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Christopher S. Holland</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Dr. Jacqueline B. Kosecoff</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Paul E. Martin</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Dr. Nirav R. Shah</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Dr. Mohsen M. Sohi</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>Re-election of Directors: Dr. Richard M. Steeves</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>To appoint Ernst &amp; Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's next annual general meeting.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>To authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst &amp; Young Chartered Accountants as the Company's statutory auditor under Irish law.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2024.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>To approve a proposal renewing the Board of Director's authority to issue shares under Irish law.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>STERIS plc</issuerName>
    <cusip>G8473T100</cusip>
    <isin>IE00BFY8C754</isin>
    <meetingDate>08/01/2024</meetingDate>
    <voteDescription>To approve a proposal renewing the Board of Director's authority to opt-out of statutory pre-emption rights under Irish law.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>21172.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>21172.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Galera Therapeutics, Inc.</issuerName>
    <cusip>36338D108</cusip>
    <isin>US36338D1081</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>To approve the liquidation and dissolution of the Company and the Plan of Liquidation and Dissolution (the &quot;Plan of Dissolution&quot;) which, if approved, will authorize the Company's Board of Directors to liquidate and dissolve the Company in accordance with the Plan of Dissolution (the &quot;Dissolution Proposal&quot;).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>EXTRAORDINARY TRANSACTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>314430.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>314430.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Galera Therapeutics, Inc.</issuerName>
    <cusip>36338D108</cusip>
    <isin>US36338D1081</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>To adjourn the Special Meeting, from time to time, to a later date or dates, even if a quorum is present, to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting to approve the Dissolution Proposal.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>314430.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>314430.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Craig Arnold</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Scott C. Donnelly</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Lidia L. Fonseca</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Andrea J. Goldsmith, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Randall J. Hogan, III</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Gregory P. Lewis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Kevin E. Lofton</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Geoffrey S. Martha</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Elizabeth G. Nabel, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the &quot;Company&quot;): Kendall J. Powell</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2025 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Approving, on an advisory basis, the Company's executive compensation;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Renewing the Board of Directors' authority to issue shares under Irish law;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; and</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medtronic Plc</issuerName>
    <cusip>G5960L103</cusip>
    <isin>IE00BTN1Y115</isin>
    <meetingDate>10/17/2024</meetingDate>
    <voteDescription>Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>215054.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>215054.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Carol Burt</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Christopher DelOrefice</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Jan De Witte</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Karen Drexler</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Michael Farrell</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Peter Farrell</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Harjit Gill</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: John Hernandez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Richard Sulpizio</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Desney Tan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Ronald Taylor</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ResMed Inc.</issuerName>
    <cusip>761152107</cusip>
    <isin>US7611521078</isin>
    <meetingDate>11/20/2024</meetingDate>
    <voteDescription>Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement (&quot;say-on-pay&quot;).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>33171.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>33171.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>State Street Institutional Investment Trust</issuerName>
    <cusip>857492706</cusip>
    <isin>US8574927062</isin>
    <meetingDate>12/06/2024</meetingDate>
    <voteDescription>To Elect a Board of Trustees: Patrick J. Riley</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>58210840.710000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>58210840.710000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>State Street Institutional Investment Trust</issuerName>
    <cusip>857492706</cusip>
    <isin>US8574927062</isin>
    <meetingDate>12/06/2024</meetingDate>
    <voteDescription>To Elect a Board of Trustees: Donna M. Rapaccioli</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>58210840.710000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>58210840.710000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>State Street Institutional Investment Trust</issuerName>
    <cusip>857492706</cusip>
    <isin>US8574927062</isin>
    <meetingDate>12/06/2024</meetingDate>
    <voteDescription>To Elect a Board of Trustees: Margaret K. McLaughlin</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>58210840.710000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>58210840.710000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>State Street Institutional Investment Trust</issuerName>
    <cusip>857492706</cusip>
    <isin>US8574927062</isin>
    <meetingDate>12/06/2024</meetingDate>
    <voteDescription>To Elect a Board of Trustees: George M. Pereira</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>58210840.710000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>58210840.710000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>State Street Institutional Investment Trust</issuerName>
    <cusip>857492706</cusip>
    <isin>US8574927062</isin>
    <meetingDate>12/06/2024</meetingDate>
    <voteDescription>To Elect a Board of Trustees: Mark E. Swanson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>58210840.710000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>58210840.710000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>State Street Institutional Investment Trust</issuerName>
    <cusip>857492706</cusip>
    <isin>US8574927062</isin>
    <meetingDate>12/06/2024</meetingDate>
    <voteDescription>To Elect a Board of Trustees: Jeanne LaPorta</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>58210840.710000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>58210840.710000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: William M. Brown</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Catherine M. Burzik</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Carrie Byington</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: R. Andrew Eckert</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Claire M. Fraser</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Jeffrey W. Henderson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Christopher Jones</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Thomas E. Polen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Timothy M. Ring</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Bertram L. Scott</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Election of Directors: Joanne Waldstreicher</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Ratification of the selection of the independent registered public accounting firm.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Becton, Dickinson and Company</issuerName>
    <cusip>075887109</cusip>
    <isin>US0758871091</isin>
    <meetingDate>01/28/2025</meetingDate>
    <voteDescription>Advisory vote to approve named executive officer compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>87457.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>87457.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Galera Therapeutics, Inc.</issuerName>
    <cusip>36338D108</cusip>
    <isin>US36338D1081</isin>
    <meetingDate>02/24/2025</meetingDate>
    <voteDescription>Election of Class II Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Lawrence Alleva</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>314430.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>314430.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Galera Therapeutics, Inc.</issuerName>
    <cusip>36338D108</cusip>
    <isin>US36338D1081</isin>
    <meetingDate>02/24/2025</meetingDate>
    <voteDescription>Election of Class II Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Kevin Lokay</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>314430.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>314430.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Galera Therapeutics, Inc.</issuerName>
    <cusip>36338D108</cusip>
    <isin>US36338D1081</isin>
    <meetingDate>02/24/2025</meetingDate>
    <voteDescription>To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>314430.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>314430.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: Raquel C. Bono, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: Frank A. D'Amelio</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: David T. Feinberg, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: Wayne A. I. Frederick, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: John W. Garratt</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: Kurt J. Hilzinger</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: Karen W. Katz</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: Marcy S. Klevorn</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: Jorge S. Mesquita</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: James A. Rechtin</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Election of Directors: Gordon Smith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Humana Inc.</issuerName>
    <cusip>444859102</cusip>
    <isin>US4448591028</isin>
    <meetingDate>04/17/2025</meetingDate>
    <voteDescription>Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18997.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>18997.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Thomas F. Frist III</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Samuel N. Hazen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Robert J. Dennis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Nancy-Ann DeParle</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: William R. Frist</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Hugh F. Johnston</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Michael W. Michelson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Wayne J. Riley M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Andrea B. Smith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Advisory vote to approve named executive officer compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>To approve the First Amendment to the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>To approve an amendment to our amended and restated certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Stockholder proposal, if properly presented at the meeting, regarding lavish golden parachutes.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Stockholder proposal, if properly presented at the meeting, regarding an amendment to Patient Safety and Quality of Care Committee charter.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>HCA Healthcare, Inc.</issuerName>
    <cusip>40412C101</cusip>
    <isin>US40412C1018</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Stockholder proposal, if properly presented at the meeting, regarding report on acquisition strategy.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>38114.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>38114.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Scott M. Brinker</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Katherine M. Sandstrom</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: John T. Thomas</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Brian G. Cartwright</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: James B. Connor</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: R. Kent Griffin, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Pamela J. Kessler</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Sara G. Lewis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Ava E. Lias-Booker</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Tommy G. Thompson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Richard A. Weiss</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Approval of 2024 executive compensation on an advisory basis.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Approval of the Healthpeak Properties, Inc. Employee Stock Purchase Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthpeak Properties, Inc.</issuerName>
    <cusip>42250P103</cusip>
    <isin>US42250P1030</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>567701.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>567701.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Darius Adamczyk</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Mary C. Beckerle</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Jennifer A. Doudna</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Joaquin Duato</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Marillyn A. Hewson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Paula A. Johnson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Hubert Joly</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Mark B. McClellan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Mark A. Weinberger</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Nadja Y. West</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Eugene A. Woods</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Advisory Vote to Approve Named Executive Officer Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Shareholder opportunity to vote on excessive golden parachutes</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Johnson &amp; Johnson</issuerName>
    <cusip>478160104</cusip>
    <isin>US4781601046</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Produce a human rights impact assessment</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>243394.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>243394.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Ronald E. Blaylock</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Albert Bourla</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Mortimer J. Buckley</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Susan Desmond-Hellmann</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Joseph J. Echevarria</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Scott Gottlieb</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Susan Hockfield</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Dan R. Littman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Shantanu Narayen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Suzanne Nora Johnson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: James Quincey</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: James C. Smith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Election of Directors: Cyrus Taraporevala</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2025</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>2025 advisory approval of executive compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Shareholder Vote Regarding Golden Parachutes</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Pfizer Inc.</issuerName>
    <cusip>717081103</cusip>
    <isin>US7170811035</isin>
    <meetingDate>04/24/2025</meetingDate>
    <voteDescription>Issue a Report Evaluating the Risks Related to Religious Discrimination Against Employees</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>ENVIRONMENT OR CLIMATE</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>DIVERSITY, EQUITY, AND INCLUSION</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>539844.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>539844.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: R. J. Alpern</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: C. Babineaux-Fontenot</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: S. E. Blount</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: R. B. Ford</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: P. Gonzalez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: M. A. Kumbier</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: D. W. McDew</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: N. McKinstry</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: M. G. O'Grady</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: M. F. Roman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: D. J. Starks</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Election of 12 Directors: J. G. Stratton</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Ratification of Ernst &amp; Young LLP As Auditors</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Abbott Laboratories</issuerName>
    <cusip>002824100</cusip>
    <isin>US0028241000</isin>
    <meetingDate>04/25/2025</meetingDate>
    <voteDescription>Say on Pay - An Advisory Vote on the Approval of Executive Compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>391721.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>391721.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Barbara L. Brasier</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Leo P. Grohowski</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Stephen H. Lockhart</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Steven J. Orlando</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Ronna E. Romney</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Richard M. Schapiro</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Dale B. Wolf</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Richard C. Zoretic</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To elect nine directors to hold office until the 2026 Annual Meeting: Joseph M. Zubretsky</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>To consider and approve the Company's 2025 Equity Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Molina Healthcare, Inc.</issuerName>
    <cusip>60855R100</cusip>
    <isin>US60855R1005</isin>
    <meetingDate>04/30/2025</meetingDate>
    <voteDescription>Stockholder proposal regarding stockholders ability to call a special stockholders meeting, if properly presented.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>23293.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>23293.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: Yoshiaki Fujimori</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: David C. Habiger</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: Edward J. Ludwig</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: Michael F. Mahoney</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: Jessica L. Mega</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: Susan E. Morano</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: Cheryl Pegus</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: John E. Sununu</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: David S. Wichmann</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Proposal to elect ten Directors: Ellen M. Zane</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the 2025 fiscal year.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Boston Scientific Corporation</issuerName>
    <cusip>101137107</cusip>
    <isin>US1011371077</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Stockholder proposal titled &quot;Support Simple Majority Vote.&quot;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>171745.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>171745.000000</sharesVoted>
        <managementRecommendation>NONE</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Inspire Medical Systems, Inc.</issuerName>
    <cusip>457730109</cusip>
    <isin>US4577301090</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Class I Directors: Cynthia B. Burks</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>75860.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>75860.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Inspire Medical Systems, Inc.</issuerName>
    <cusip>457730109</cusip>
    <isin>US4577301090</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Class I Directors: Timothy P. Herbert</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>75860.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>75860.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Inspire Medical Systems, Inc.</issuerName>
    <cusip>457730109</cusip>
    <isin>US4577301090</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Class I Directors: Shawn T McCormick</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>75860.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>75860.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Inspire Medical Systems, Inc.</issuerName>
    <cusip>457730109</cusip>
    <isin>US4577301090</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>75860.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>75860.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Inspire Medical Systems, Inc.</issuerName>
    <cusip>457730109</cusip>
    <isin>US4577301090</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>75860.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>75860.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Craig H. Barratt, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Joseph C. Beery</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Lewis Chew</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Gary S. Guthart, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Amal M. Johnson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Sreelakshmi Kolli</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Amy L. Ladd, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Keith R. Leonard, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Jami Dover Nachtsheim</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: Monica P. Reed, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>Election of Directors: David J. Rosa</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To approve, by advisory vote, the compensation of the Company's Named Executive Officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>The stockholder proposal purportedly &quot;to improve the executive compensation program,&quot; if properly presented at the Annual Meeting.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Intuitive Surgical, Inc.</issuerName>
    <cusip>46120E602</cusip>
    <isin>US46120E6023</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>The stockholder proposal that is titled &quot;requesting a shareholder approval requirement for excessive golden parachutes,&quot; if properly presented at the Annual Meeting.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>55557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>55557.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Bradley A. Alford</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Orlando D. Ashford</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Julia M. Brown</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Kevin Egan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Adriana Karaboutis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Jeffrey B. Kindler</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Patrick Lockwood-Taylor</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Albert A. Manzone</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Donal O'Connor</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Geoffrey M. Parker</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Jonas Samuelson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To ratify, in a non-binding advisory vote, the appointment of Ernst &amp; Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To provide advisory approval of the Company's executive compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To renew the Board's authority to issue shares under Irish law;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To approve an increase in the maximum number of directors who may be appointed to the Board;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Perrigo Company plc</issuerName>
    <cusip>G97822103</cusip>
    <isin>IE00BGH1M568</isin>
    <meetingDate>05/01/2025</meetingDate>
    <voteDescription>To approve amendments to the Company's Articles of Association;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>28292.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>28292.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Eli Lilly and Company</issuerName>
    <cusip>532457108</cusip>
    <isin>US5324571083</isin>
    <meetingDate>05/05/2025</meetingDate>
    <voteDescription>Election of the following directors, each to serve a three-year term: Ralph Alvarez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119192.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>119192.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Eli Lilly and Company</issuerName>
    <cusip>532457108</cusip>
    <isin>US5324571083</isin>
    <meetingDate>05/05/2025</meetingDate>
    <voteDescription>Election of the following directors, each to serve a three-year term: Mary Lynne Hedley</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119192.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119192.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Eli Lilly and Company</issuerName>
    <cusip>532457108</cusip>
    <isin>US5324571083</isin>
    <meetingDate>05/05/2025</meetingDate>
    <voteDescription>Election of the following directors, each to serve a three-year term: Kimberly Johnson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119192.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119192.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Eli Lilly and Company</issuerName>
    <cusip>532457108</cusip>
    <isin>US5324571083</isin>
    <meetingDate>05/05/2025</meetingDate>
    <voteDescription>Election of the following directors, each to serve a three-year term: Juan Luciano</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119192.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119192.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Eli Lilly and Company</issuerName>
    <cusip>532457108</cusip>
    <isin>US5324571083</isin>
    <meetingDate>05/05/2025</meetingDate>
    <voteDescription>Approval, on an advisory basis, of the compensation paid to the company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119192.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119192.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Eli Lilly and Company</issuerName>
    <cusip>532457108</cusip>
    <isin>US5324571083</isin>
    <meetingDate>05/05/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the independent auditor for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119192.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>119192.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Eli Lilly and Company</issuerName>
    <cusip>532457108</cusip>
    <isin>US5324571083</isin>
    <meetingDate>05/05/2025</meetingDate>
    <voteDescription>Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SHAREHOLDER RIGHTS AND DEFENSES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119192.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119192.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Eli Lilly and Company</issuerName>
    <cusip>532457108</cusip>
    <isin>US5324571083</isin>
    <meetingDate>05/05/2025</meetingDate>
    <voteDescription>Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119192.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119192.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Peter J. Arduini</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Christopher S. Boerner, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Julia A. Haller, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Michael R. McMullen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Paula A. Price</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Derica W. Rice</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Theodore R. Samuels</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Karen H. Vousden, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Election of Directors: Phyllis R. Yale</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Advisory Vote to Approve the Compensation of our Named Executive Officers</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Ratification of the Appointment of an Independent Registered Public Accounting Firm</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Shareholder Proposal on Corporate Financial Sustainability</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>ENVIRONMENT OR CLIMATE</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>DIVERSITY, EQUITY, AND INCLUSION</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Bristol-Myers Squibb Company</issuerName>
    <cusip>110122108</cusip>
    <isin>US1101221083</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>Shareholder Proposal on a Request to Cease DEI Efforts</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>ENVIRONMENT OR CLIMATE</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>DIVERSITY, EQUITY, AND INCLUSION</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>426866.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>426866.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri List</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Jessica L. Mega, MD, MPH</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: John T. Schwieters</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To ratify the selection of Ernst &amp; Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Danaher Corporation</issuerName>
    <cusip>235851102</cusip>
    <isin>US2358511028</isin>
    <meetingDate>05/06/2025</meetingDate>
    <voteDescription>To approve on an advisory basis the Company's named executive officer compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>88103.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>88103.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs, if properly presented at the Annual Meeting.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIVERSITY, EQUITY, AND INCLUSION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process, if properly presented at the Annual Meeting.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Gilead Sciences, Inc.</issuerName>
    <cusip>375558103</cusip>
    <isin>US3755581036</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors, if properly presented at the Annual Meeting.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>ENVIRONMENT OR CLIMATE</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>DIVERSITY, EQUITY, AND INCLUSION</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>119573.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>119573.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEXX Laboratories, Inc.</issuerName>
    <cusip>45168D104</cusip>
    <isin>US45168D1046</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>Election of Directors (Proposal One): Stuart M. Essig</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>4988.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>4988.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEXX Laboratories, Inc.</issuerName>
    <cusip>45168D104</cusip>
    <isin>US45168D1046</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>Election of Directors (Proposal One): Jonathan J. Mazelsky</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>4988.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>4988.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEXX Laboratories, Inc.</issuerName>
    <cusip>45168D104</cusip>
    <isin>US45168D1046</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>Election of Directors (Proposal One): M. Anne Szostak</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>4988.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>4988.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEXX Laboratories, Inc.</issuerName>
    <cusip>45168D104</cusip>
    <isin>US45168D1046</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>4988.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>4988.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEXX Laboratories, Inc.</issuerName>
    <cusip>45168D104</cusip>
    <isin>US45168D1046</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>4988.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>4988.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEXX Laboratories, Inc.</issuerName>
    <cusip>45168D104</cusip>
    <isin>US45168D1046</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>Amend Certificate of Incorporation to Remove Supermajority Voting Provisions (Proposal Four).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>4988.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>4988.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEXX Laboratories, Inc.</issuerName>
    <cusip>45168D104</cusip>
    <isin>US45168D1046</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>Amend Certificate of Incorporation to Reflect New Delaware Law Provisions Allowing for Officer Exculpation (Proposal Five).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>4988.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>4988.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>IDEXX Laboratories, Inc.</issuerName>
    <cusip>45168D104</cusip>
    <isin>US45168D1046</isin>
    <meetingDate>05/07/2025</meetingDate>
    <voteDescription>Shareholder Proposal Regarding the Annual Election of Directors (Proposal Six).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SHAREHOLDER RIGHTS AND DEFENSES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>4988.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>4988.000000</sharesVoted>
        <managementRecommendation>NONE</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Kevin R. Sayer</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Steven R. Altman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Nicholas Augustinos</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Richard A. Collins</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Rimma Driscoll</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Mark G. Foletta</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Renee Gala</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Bridgette P. Heller</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Kyle Malady</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To ratify the selection by the Audit Committee of our Board of Directors of Deloitte &amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To approve our Amended and Restated 2015 Equity Incentive Plan (as amended and restated) to, among other things, increase the number of shares reserved for issuance thereunder by 3,400,000 shares.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>DexCom, Inc.</issuerName>
    <cusip>252131107</cusip>
    <isin>US2521311074</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>To approve our Amended and Restated 2015 Employee Stock Purchase Plan to, among other things, increase the number of shares reserved for issuance thereunder by 8,000,000 shares.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>117166.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>117166.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Mary K. Brainerd</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Giovanni Caforio, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Kevin A. Lobo</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Emmanuel P. Maceda</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Sherilyn S. McCoy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Rachel M. Ruggeri</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Andrew K. Silvernail</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Lisa M. Skeete Tatum</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Ronda E. Stryker</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Election of Ten Directors: Rajeev Suri</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Ratification of Appointment of Ernst &amp; Young LLP as Our Independent Registered Public Accounting Firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Approval of the 2011 Long-Term Incentive Plan, as Amended and Restated.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Approval of the 2011 Performance Incentive Award Plan, as Amended and Restated.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Approval of the 2008 Stock Purchase Plan, as Amended and Restated.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Advisory Vote to Approve Named Executive Officer Compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Stryker Corporation</issuerName>
    <cusip>863667101</cusip>
    <isin>US8636671013</isin>
    <meetingDate>05/08/2025</meetingDate>
    <voteDescription>Shareholder Proposal to Support Transparency in Political Spending.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>52577.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>52577.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AbbVie Inc.</issuerName>
    <cusip>00287Y109</cusip>
    <isin>US00287Y1091</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Class I Directors: William H.L. Burnside</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>275548.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>275548.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AbbVie Inc.</issuerName>
    <cusip>00287Y109</cusip>
    <isin>US00287Y1091</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Class I Directors: Thomas C. Freyman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>275548.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>275548.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AbbVie Inc.</issuerName>
    <cusip>00287Y109</cusip>
    <isin>US00287Y1091</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Class I Directors: Brett J. Hart</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>275548.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>275548.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AbbVie Inc.</issuerName>
    <cusip>00287Y109</cusip>
    <isin>US00287Y1091</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Election of Class I Directors: Edward J. Rapp</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>275548.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>275548.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AbbVie Inc.</issuerName>
    <cusip>00287Y109</cusip>
    <isin>US00287Y1091</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Ratification of Ernst &amp; Young LLP as AbbVie's independent registered public accounting firm for 2025</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>275548.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>275548.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AbbVie Inc.</issuerName>
    <cusip>00287Y109</cusip>
    <isin>US00287Y1091</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Say on Pay - An advisory vote on the approval of executive compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>275548.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>275548.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AbbVie Inc.</issuerName>
    <cusip>00287Y109</cusip>
    <isin>US00287Y1091</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>275548.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>275548.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>AbbVie Inc.</issuerName>
    <cusip>00287Y109</cusip>
    <isin>US00287Y1091</isin>
    <meetingDate>05/09/2025</meetingDate>
    <voteDescription>Stockholder Proposal - to Implement Simple Majority Vote</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>275548.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>275548.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: Susan W. Brooks</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: Ronald L. Burgess, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: John A. Clerico</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: Michael Dinkins</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: James S. Ely III</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: John A. Fry</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: Joseph A. Hastings, D.M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: Tim L. Hingtgen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: Elizabeth T. Hirsch</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: William Norris Jennings, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: K. Ranga Krishnan, MBBS</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: Fawn D. Lopez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: Wayne T. Smith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors: H. James Williams, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors on March 12, 2025, subject to stockholder approval.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Proposal to approve the amendment to the Restated Certificate of Incorporation of Community Health Systems, Inc., to permit exculpation of officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Community Health Systems, Inc.</issuerName>
    <cusip>203668108</cusip>
    <isin>US2036681086</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Proposal to ratify the selection of Deloitte &amp; Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>409762.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>409762.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Rallybio Corporation</issuerName>
    <cusip>75120L100</cusip>
    <isin>US75120L1008</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Class I Directors: Martin W. Mackay</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>594616.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>594616.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Rallybio Corporation</issuerName>
    <cusip>75120L100</cusip>
    <isin>US75120L1008</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Class I Directors: Paula Soteropoulos</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>594616.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>594616.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Rallybio Corporation</issuerName>
    <cusip>75120L100</cusip>
    <isin>US75120L1008</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as the independent registered public accounting firm.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>594616.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>594616.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Melody C. Barnes</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Theodore R. Bigman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Debra A. Cafaro</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Michael J. Embler</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Matthew J. Lustig</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Roxanne M. Martino</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Marguerite M. Nader</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Sean P. Nolan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Walter C. Rakowich</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Joe V. Rodriguez, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Sumit Roy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Election of Directors of Ventas, Inc.: Maurice S. Smith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Approval, on an advisory basis, of the compensation of named executive officers of Ventas, Inc.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Ratification of the selection of KPMG LLP as independent registered public accounting firm of Ventas, Inc. for fiscal year 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Approval of an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to increase the number of authorized shares of common stock.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Ventas, Inc.</issuerName>
    <cusip>92276F100</cusip>
    <isin>US92276F1003</isin>
    <meetingDate>05/13/2025</meetingDate>
    <voteDescription>Approval of an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to limit the liability of certain officers as permitted by Delaware Law.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>106216.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>106216.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Cytokinetics, Incorporated</issuerName>
    <cusip>23282W605</cusip>
    <isin>US23282W6057</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: John T. Henderson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178066.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>178066.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Cytokinetics, Incorporated</issuerName>
    <cusip>23282W605</cusip>
    <isin>US23282W6057</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: B. Lynne Parshall</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178066.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>178066.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Cytokinetics, Incorporated</issuerName>
    <cusip>23282W605</cusip>
    <isin>US23282W6057</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: Muna Bhanji</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178066.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>178066.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Cytokinetics, Incorporated</issuerName>
    <cusip>23282W605</cusip>
    <isin>US23282W6057</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To approve the amendment and restatement of the Cytokinetics Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under such plan by 5,000,000 shares of common stock and (ii) provide for limitations on the maximum grant value that non-executive directors may receive under such plan of $1,000,000 for annual grants to continuing directors and $1,250,000 for the initial grant to new directors.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178066.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>178066.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Cytokinetics, Incorporated</issuerName>
    <cusip>23282W605</cusip>
    <isin>US23282W6057</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To approve an amendment to Cytokinetics, Incorporated's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common available for issuance by Cytokinetics, Incorporated from 163,000,000 to 326,000,000 shares of common stock.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178066.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>178066.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Cytokinetics, Incorporated</issuerName>
    <cusip>23282W605</cusip>
    <isin>US23282W6057</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To ratify the appointment by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the Cytokinetics, Incorporated's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178066.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>178066.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Cytokinetics, Incorporated</issuerName>
    <cusip>23282W605</cusip>
    <isin>US23282W6057</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>178066.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>178066.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Elevance Health, Inc.</issuerName>
    <cusip>036752103</cusip>
    <isin>US0367521038</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>Election of Directors: Susan D. DeVore</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>64684.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>64684.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Elevance Health, Inc.</issuerName>
    <cusip>036752103</cusip>
    <isin>US0367521038</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>Election of Directors: Bahija Jallal</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>64684.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>64684.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Elevance Health, Inc.</issuerName>
    <cusip>036752103</cusip>
    <isin>US0367521038</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>Election of Directors: Ryan M. Schneider</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>64684.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>64684.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Elevance Health, Inc.</issuerName>
    <cusip>036752103</cusip>
    <isin>US0367521038</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>Advisory vote to approve the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>64684.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>64684.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Elevance Health, Inc.</issuerName>
    <cusip>036752103</cusip>
    <isin>US0367521038</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the independent registered public accounting firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>64684.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>64684.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Elevance Health, Inc.</issuerName>
    <cusip>036752103</cusip>
    <isin>US0367521038</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIVERSITY, EQUITY, AND INCLUSION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>64684.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>64684.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Jeffrey M. Busch</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Matthew Cypher</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Ronald Marston</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Henry E. Cole</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Zhang Huiqi</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Paula R. Crowley</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Lori Wittman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Global Medical REIT Inc.</issuerName>
    <cusip>37954A204</cusip>
    <isin>US37954A2042</isin>
    <meetingDate>05/14/2025</meetingDate>
    <voteDescription>To ratify the appointment of Deloitte &amp; Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>31668.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>31668.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Elizabeth M. Anderson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Barbara W. Bodem</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Athena Countouriotis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Willard Dere</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Mark J. Enyedy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Alexander Hardy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Maykin Ho</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Robert J. Hombach</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Richard A. Meier</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Timothy P. Walbert</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>BioMarin Pharmaceutical Inc.</issuerName>
    <cusip>09061G101</cusip>
    <isin>US09061G1013</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>135939.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>135939.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Nancy H. Agee</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Thomas N. Bohjalian</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Ajay Gupta</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: David B. Henry</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: James J. Kilroy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Jay P. Leupp</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Peter F. Lyle</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Constance B. Moore</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Glenn Rufrano</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Christann M. Vasquez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>Election of Directors: Donald C. Wood</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>To ratify the appointment of BDO USA, P.C. as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2025 fiscal year.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Healthcare Realty Trust Incorporated</issuerName>
    <cusip>42226K105</cusip>
    <isin>US42226K1051</isin>
    <meetingDate>05/20/2025</meetingDate>
    <voteDescription>To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the stockholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2025 Annual Meeting of Stockholders.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>25119.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>25119.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Frances Arnold, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Caroline D. Dorsa</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Robert S. Epstein, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Scott Gottlieb, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Gary S. Guthart, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Keith A. Meister</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Anna Richo</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Philip W. Schiller</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Susan E. Siegel</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Jacob Thaysen, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Scott B. Ullem</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 28, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Illumina, Inc.</issuerName>
    <cusip>452327109</cusip>
    <isin>US4523271090</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To approve the Second Amended and Restated 2015 Stock and Incentive Plan of Illumina, Inc.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>36513.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>36513.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors. Nominees RECOMMENDED by the Company: Robert G. Adams</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors. Nominees RECOMMENDED by the Company: Robert W. Chapin, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors. Nominees RECOMMENDED by the Company: James R. Jobe</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors. Nominees RECOMMENDED by the Company: Candice W. Todd</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors. Dissident Nominees OPPOSED by the Company: James Hoffmann</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors. Dissident Nominees OPPOSED by the Company: A. Adam Troso</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Approve an amendment to the Company's Articles of Incorporation, as amended, to declassify the Board of Directors.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SHAREHOLDER RIGHTS AND DEFENSES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Approve, on a non-binding advisory basis, the compensation paid to our named executive officers as disclosed in the accompanying Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Ratify the audit committee's selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. LAND &amp; BUILDINGS NOMINEES: James Hoffmann</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. LAND &amp; BUILDINGS NOMINEES: A. Adam Troso</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES UNOPPOSED BY LAND &amp; BUILDINGS NOMINEES: Candice W. Todd</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES UNOPPOSED BY LAND &amp; BUILDINGS NOMINEES: Robert W. Chapin, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES OPPOSED BY LAND &amp; BUILDINGS NOMINEES: Robert G. Adams</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES OPPOSED BY LAND &amp; BUILDINGS NOMINEES: James R. Jobe</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>The Company's proposal to approve an amendment to the Company's Articles of Incorporation, as amended, to declassify the Board.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SHAREHOLDER RIGHTS AND DEFENSES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>The Company's proposal to approve, on an advisory basis, of the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>NONE</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>National Health Investors, Inc.</issuerName>
    <cusip>63633D104</cusip>
    <isin>US63633D1046</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>The Company's proposal to ratify the Audit Committee's selection of BDO USA, P.C. as the Company's independent registered public accounting firm for fiscal year 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>5596.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>5596.000000</sharesVoted>
        <managementRecommendation>NONE</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Neurocrine Biosciences, Inc.</issuerName>
    <cusip>64125C109</cusip>
    <isin>US64125C1099</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Kyle W. Gano, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>48947.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>48947.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Neurocrine Biosciences, Inc.</issuerName>
    <cusip>64125C109</cusip>
    <isin>US64125C1099</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Richard F. Pops</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>48947.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>48947.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Neurocrine Biosciences, Inc.</issuerName>
    <cusip>64125C109</cusip>
    <isin>US64125C1099</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Shalini Sharp</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>48947.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>48947.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Neurocrine Biosciences, Inc.</issuerName>
    <cusip>64125C109</cusip>
    <isin>US64125C1099</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Stephen A. Sherwin, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>48947.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>48947.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Neurocrine Biosciences, Inc.</issuerName>
    <cusip>64125C109</cusip>
    <isin>US64125C1099</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Advisory vote on the compensation paid to the Company's named executive officers;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>48947.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>48947.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Neurocrine Biosciences, Inc.</issuerName>
    <cusip>64125C109</cusip>
    <isin>US64125C1099</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To approve the Company's 2025 Equity Incentive Plan;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>48947.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>48947.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Neurocrine Biosciences, Inc.</issuerName>
    <cusip>64125C109</cusip>
    <isin>US64125C1099</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To approve an amendment and restatement of the Company's 2018 Employee Stock Purchase Plan; and</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>48947.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>48947.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Neurocrine Biosciences, Inc.</issuerName>
    <cusip>64125C109</cusip>
    <isin>US64125C1099</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>48947.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>48947.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Rebecca Robertson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Myoungil Cha</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Peyton Howell</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Joao Malagueira</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Kathleen McGroddy-Goetz</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: John Sheridan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Rajwant Sodhi</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To elect eight directors for a one-year term expiring at the 2026 annual meeting of stockholders: Christopher Twomey</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To approve, on a non-binding, advisory basis, the frequency of future stockholder advisory votes to approve the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>ONE YEAR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tandem Diabetes Care, Inc.</issuerName>
    <cusip>875372203</cusip>
    <isin>US8753722037</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>186024.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>186024.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Marc N. Casper</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Nelson J. Chai</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Ruby R. Chandy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: C. Martin Harris</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Tyler Jacks</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Jennifer M. Johnson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: R. Alexandra Keith</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Karen S. Lynch</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: James C. Mullen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Debora L. Spar</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Scott M. Sperling</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Dion J. Weisler</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>An advisory vote to approve named executive officer compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Thermo Fisher Scientific Inc.</issuerName>
    <cusip>883556102</cusip>
    <isin>US8835561023</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Shareholder proposal.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>69382.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>69382.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Paul M. Bisaro</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Vanessa Broadhurst</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Frank A. D'Amelio</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Gavin D.K. Hattersley</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Sanjay Khosla</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Antoinette R. Leatherberry</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Michael B. McCallister</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Gregory Norden</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Louise M. Parent</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Kristin C. Peck</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Willie M. Reed</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Election of Directors: Mark Stetter</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Advisory vote to approve our executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Zoetis Inc.</issuerName>
    <cusip>98978V103</cusip>
    <isin>US98978V1035</isin>
    <meetingDate>05/21/2025</meetingDate>
    <voteDescription>Shareholder proposal regarding a special shareholder meeting improvement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>103497.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>103497.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Insulet Corporation</issuerName>
    <cusip>45784P101</cusip>
    <isin>US45784P1012</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Jessica Hopfield</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16263.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>16263.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Insulet Corporation</issuerName>
    <cusip>45784P101</cusip>
    <isin>US45784P1012</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Ashley A. McEvoy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16263.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>16263.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Insulet Corporation</issuerName>
    <cusip>45784P101</cusip>
    <isin>US45784P1012</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Elizabeth H. Weatherman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16263.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>16263.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Insulet Corporation</issuerName>
    <cusip>45784P101</cusip>
    <isin>US45784P1012</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>To approve, on a non-binding, advisory basis, the compensation of certain executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16263.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>16263.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Insulet Corporation</issuerName>
    <cusip>45784P101</cusip>
    <isin>US45784P1012</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>To approve the Insulet Corporation 2025 Stock Option and Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16263.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>16263.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Insulet Corporation</issuerName>
    <cusip>45784P101</cusip>
    <isin>US45784P1012</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>16263.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>16263.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: Elizabeth A. Floegel</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: Dr. Alison L. Hannah</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: Michael A. Kelly</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: David B. Perez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: Felicia Williams</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of the directors named in the proxy statement as set forth below: Anthony P. Zook</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Recommend, on a non-binding advisory basis, the Frequency of Future Advisory Votes on Executive Compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>ONE YEAR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Approval of the First Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>NeoGenomics, Inc.</issuerName>
    <cusip>64049M209</cusip>
    <isin>US64049M2098</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Ratification of the Appointment of Deloitte &amp; Touche LLP as the Company's Independent Registered Public Accounting Firm.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>299811.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>299811.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Saumya Sutaria</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: J. Robert Kerrey</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Vineeta Agarwala</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: James L. Bierman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Roy Blunt</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Richard W. Fisher</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Meghan M. FitzGerald</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Cecil D. Haney</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Christopher S. Lynch</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Richard J. Mark</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Tammy Romo</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Stephen H. Rusckowski</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Nadja Y. West</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the Company's executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>To ratify the selection of Deloitte &amp; Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Tenet Healthcare Corporation</issuerName>
    <cusip>88033G407</cusip>
    <isin>US88033G4073</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>To report on strategies and programs for improving maternal health outcomes.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>62245.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>62245.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Kenneth J. Bacon</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Karen B. DeSalvo</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Andrew Gundlach</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Dennis G. Lopez</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Shankh Mitra</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Ade J. Patton</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Sergio D. Rivera</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Johnese M. Spisso</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>Election of Directors: Kathryn M. Sullivan</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>The ratification of the selection of Ernst &amp; Young LLP as Welltower Inc.'s independent registered public accounting firm for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>The approval, on an advisory basis, of the compensation of the named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Welltower Inc.</issuerName>
    <cusip>95040Q104</cusip>
    <isin>US95040Q1040</isin>
    <meetingDate>05/22/2025</meetingDate>
    <voteDescription>The approval of the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>51783.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>51783.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>Advisory vote to approve our executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Amgen Inc.</issuerName>
    <cusip>031162100</cusip>
    <isin>US0311621009</isin>
    <meetingDate>05/23/2025</meetingDate>
    <voteDescription>To ratify the selection of Ernst &amp; Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>65851.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>65851.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Douglas M. Baker, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Mary Ellen Coe</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Pamela J. Craig</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Robert M. Davis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Thomas H. Glocer</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Surendralal L. Karsanbhai</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Risa J. Lavizzo-Mourey, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Stephen L. Mayo, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Paul B. Rothman, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Patricia F. Russo</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Christine E. Seidman, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Inge G. Thulin</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Election of Directors: Kathy J. Warden</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Non-binding advisory vote to approve the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Ratification of the appointment of the Company's independent registered public accounting firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Shareholder proposal regarding a human rights impact assessment.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Shareholder proposal regarding a tax transparency report.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Shareholder proposal to revisit DEl goals in executive pay incentives.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>ENVIRONMENT OR CLIMATE</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>DIVERSITY, EQUITY, AND INCLUSION</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Merck &amp; Co., Inc.</issuerName>
    <cusip>58933Y105</cusip>
    <isin>US58933Y1055</isin>
    <meetingDate>05/27/2025</meetingDate>
    <voteDescription>Shareholder proposal regarding a report on civil liberties in advertising services.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>ENVIRONMENT OR CLIMATE</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>DIVERSITY, EQUITY, AND INCLUSION</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>OTHER SOCIAL ISSUES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>424906.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>424906.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Cornelia Cheng</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: David L. Gruber</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Jeffrey C. Hawken</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Bradley J. Preber</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Wendy L. Simpson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Timothy J. Triche</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>Advisory vote to approve named executive officer compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>Ratification of independent registered public accounting firm.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LTC Properties, Inc.</issuerName>
    <cusip>502175102</cusip>
    <isin>US5021751020</isin>
    <meetingDate>05/28/2025</meetingDate>
    <voteDescription>To approve the amendment and restatement of our company's Charter to increase the number of authorized shares of common stock from 60,000,000 shares to 110,000,000 shares.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>166842.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>166842.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Acadia Healthcare Company, Inc.</issuerName>
    <cusip>00404A109</cusip>
    <isin>US00404A1097</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Directors: Jason R. Bernhard</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>108522.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>108522.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Acadia Healthcare Company, Inc.</issuerName>
    <cusip>00404A109</cusip>
    <isin>US00404A1097</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Directors: William F. Grieco</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>108522.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>108522.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Acadia Healthcare Company, Inc.</issuerName>
    <cusip>00404A109</cusip>
    <isin>US00404A1097</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Directors: R. David Kelly</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>108522.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>108522.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Acadia Healthcare Company, Inc.</issuerName>
    <cusip>00404A109</cusip>
    <isin>US00404A1097</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Directors: Reeve B. Waud</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>108522.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>108522.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Acadia Healthcare Company, Inc.</issuerName>
    <cusip>00404A109</cusip>
    <isin>US00404A1097</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Approve an amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>108522.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>108522.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Acadia Healthcare Company, Inc.</issuerName>
    <cusip>00404A109</cusip>
    <isin>US00404A1097</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>108522.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>108522.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Acadia Healthcare Company, Inc.</issuerName>
    <cusip>00404A109</cusip>
    <isin>US00404A1097</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Advisory vote on the frequency of a non-binding advisory vote on the Compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>108522.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>ONE YEAR</howVoted>
        <sharesVoted>108522.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Acadia Healthcare Company, Inc.</issuerName>
    <cusip>00404A109</cusip>
    <isin>US00404A1097</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>108522.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>108522.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Trustees: Nominees (for Independent Trustee): Alan Felder</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Trustees: Nominees (for Independent Trustee): Lisa Harris Jones</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Trustees: Nominees (for Independent Trustee): Phyllis M. Hollis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Trustees: Nominees (for Independent Trustee): Dawn K. Neher</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Trustees: Nominees (for Independent Trustee): Jeffrey P. Somers</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Trustees: Nominees (for Managing Trustee): Christopher J. Bilotto</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Election of Trustees: Nominees (for Managing Trustee): Adam Portnoy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Advisory vote to approve executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Approval of the Diversified Healthcare Trust Second Amended and Restated 2012 Equity Compensation Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Diversified Healthcare Trust</issuerName>
    <cusip>25525P107</cusip>
    <isin>US25525P1075</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as independent auditors to serve for the 2025 fiscal year.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>293879.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>293879.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: Edward K. Aldag, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: G. Steven Dawson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: R. Steven Hamner</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: Caterina A. Mozingo</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: Emily W. Murphy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: Elizabeth N. Pitman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: D. Paul Sparks, Jr.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: Michael G. Stewart</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To elect nine directors: C. Reynolds Thompson, III</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Medical Properties Trust, Inc.</issuerName>
    <cusip>58463J304</cusip>
    <isin>US58463J3041</isin>
    <meetingDate>05/29/2025</meetingDate>
    <voteDescription>To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>266557.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>266557.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: Charles Baker</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: Timothy Flynn</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: Paul Garcia</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: Kristen Gil</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: Stephen Hemsley</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: Michele Hooper</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: F. William McNabb III</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: Valerie Montgomery Rice, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Election of Directors: John Noseworthy, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Advisory approval of the Company's executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>UnitedHealth Group Incorporated</issuerName>
    <cusip>91324P102</cusip>
    <isin>US91324P1021</isin>
    <meetingDate>06/02/2025</meetingDate>
    <voteDescription>If properly presented at the 2025 Annual Meeting of Shareholders, the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>174958.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>174958.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Accept Financial Statements and Statutory Reports</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Treatment of Net Loss</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Discharge of Board and Senior Management</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reelect Anthony Rosenberg as Director and Board Chair</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reelect Christina Ackermann as Director</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reelect Lionel Carnot as Director</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reelect Arshad Khanani as Director</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reelect Martijn Kleijwegt as Director</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reelect Geraldine O'Keeffe as Director</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reelect Riad Sherif as Director</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reelect Robert Warner as Director</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reappoint Christina Ackermann as Member of the Compensation Committee</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Reappoint Lionel Carnot as Member of the Compensation Committee</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Appoint Robert Warner as Member of the Compensation Committee</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Ratify PricewaterhouseCoopers SA as Statutory Auditors</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Designate PST Legal AG as Independent Proxy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Fixed Remuneration of Directors in the Amount of USD 572,000</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Equity-Based Remuneration of Directors in the Amount of USD 2.2 Million</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Fixed Remuneration of Executive Committee in the Amount of USD 2.5 Million</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Variable Remuneration of Executive Committee in the Amount of USD 1.8 Million</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Equity-Based Remuneration of Executive Committee in the Amount of USD 15.5 Million</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Remuneration Report (Non-Binding)</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Creation of Capital Band within the Upper Limit of CHF 818,005 and the Lower Limit of CHF 545,337 with or without Exclusion of Preemptive Rights</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Approve Creation of CHF 124,800 Pool of Conditional Capital for Employee Equity Plans</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Oculis Holding AG</issuerName>
    <cusip>H5870P102</cusip>
    <isin>CH1242303498</isin>
    <meetingDate>06/04/2025</meetingDate>
    <voteDescription>Transact Other Business (Voting)</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>0.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
  </proxyTable>
  <proxyTable>
    <issuerName>Sarepta Therapeutics, Inc.</issuerName>
    <cusip>803607100</cusip>
    <isin>US8036071004</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: RICHARD J. BARRY</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>198904.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>198904.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sarepta Therapeutics, Inc.</issuerName>
    <cusip>803607100</cusip>
    <isin>US8036071004</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: M. KATHLEEN BEHRENS, PH.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>198904.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>198904.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sarepta Therapeutics, Inc.</issuerName>
    <cusip>803607100</cusip>
    <isin>US8036071004</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: STEPHEN L. MAYO, PH.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>198904.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>198904.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sarepta Therapeutics, Inc.</issuerName>
    <cusip>803607100</cusip>
    <isin>US8036071004</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: CLAUDE NICAISE, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>198904.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>198904.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sarepta Therapeutics, Inc.</issuerName>
    <cusip>803607100</cusip>
    <isin>US8036071004</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>198904.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>198904.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sarepta Therapeutics, Inc.</issuerName>
    <cusip>803607100</cusip>
    <isin>US8036071004</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>APPROVE AN AMENDMENT TO THE COMPANY'S 2018 EQUITY INCENTIVE PLAN (THE &quot;2018 PLAN&quot;) TO INCREASE THE MAXIMUM AGGREGATE NUMBER OF SHARES OF COMMON STOCK THAT MAY BE ISSUED PURSUANT TO AWARDS GRANTED UNDER THE 2018 PLAN BY 4,300,000 SHARES TO 17,487,596 SHARES</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>198904.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>198904.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sarepta Therapeutics, Inc.</issuerName>
    <cusip>803607100</cusip>
    <isin>US8036071004</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>APPROVE AN AMENDMENT TO THE AMENDED AND RESTATED 2013 EMPLOYEE STOCK PURCHASE PLAN (AS AMENDED AND RESTATED ON JUNE 27, 2016, AND AMENDED ON JUNE 6, 2019 AND ON JUNE 8, 2023) (THE &quot;2016 ESPP&quot;) TO INCREASE THE NUMBER OF SHARES OF THE COMPANY'S COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE 2016 ESPP BY 300,000 SHARES TO 1,700,000 SHARES</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>198904.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>198904.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sarepta Therapeutics, Inc.</issuerName>
    <cusip>803607100</cusip>
    <isin>US8036071004</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>RATIFY THE SELECTION OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT YEAR ENDING DECEMBER 31, 2025</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>198904.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>198904.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sera Prognostics, Inc.</issuerName>
    <cusip>81749D107</cusip>
    <isin>US81749D1072</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Directors: Jane F. Barlow, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>640000.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>640000.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sera Prognostics, Inc.</issuerName>
    <cusip>81749D107</cusip>
    <isin>US81749D1072</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Election of Directors: Mansoor Raza Mirza, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>640000.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>640000.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sera Prognostics, Inc.</issuerName>
    <cusip>81749D107</cusip>
    <isin>US81749D1072</isin>
    <meetingDate>06/05/2025</meetingDate>
    <voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>640000.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>640000.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Election of Directors: Kapila K. Anand</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Election of Directors: Craig R. Callen</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Election of Directors: Dr. Lisa C. Egbuonu-Davis</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Election of Directors: Barbara B. Hill</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Election of Directors: Kevin J. Jacobs</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Election of Directors: C. Taylor Pickett</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Election of Directors: Stephen D. Plavin</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Election of Directors: Burke W. Whitman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Ratification of the selection of Ernst &amp; Young LLP as our independent auditor for fiscal year 2025</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Approval, on an advisory basis, of executive compensation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Omega Healthcare Investors, Inc.</issuerName>
    <cusip>681936100</cusip>
    <isin>US6819361006</isin>
    <meetingDate>06/06/2025</meetingDate>
    <voteDescription>Approval of the Amendment to our Charter to increase the number of authorized shares of our common stock</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>297889.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>297889.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Adaptive Biotechnologies Corporation</issuerName>
    <cusip>00650F109</cusip>
    <isin>US00650F1093</isin>
    <meetingDate>06/10/2025</meetingDate>
    <voteDescription>To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders: Chad Robins</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>272784.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>272784.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Adaptive Biotechnologies Corporation</issuerName>
    <cusip>00650F109</cusip>
    <isin>US00650F1093</isin>
    <meetingDate>06/10/2025</meetingDate>
    <voteDescription>To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>272784.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>272784.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Adaptive Biotechnologies Corporation</issuerName>
    <cusip>00650F109</cusip>
    <isin>US00650F1093</isin>
    <meetingDate>06/10/2025</meetingDate>
    <voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2025; and</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>272784.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>272784.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): J. Christopher Barry</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): Francesco Bianchi</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): Stacy Enxing Seng</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): William Kozy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): Vladimir Makatsaria</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): Dr. Sharon O'Kane</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): Susan Podlogar</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): Todd Schermerhorn</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): Brooke Story</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 (&quot;2026 AGM&quot;): Peter Wilver</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers (&quot;US Say on Pay&quot;).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership (&quot;PwC-US&quot;), as the Company's independent registered public accounting firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To approve the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To approve the LivaNova PLC 2025 Director Incentive Award Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the &quot;Companies Act&quot;), to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of pounds10,904,831, provided that: (A) (unless previously revoked, varied or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or agreements as if this authority had not expired; and (B) this authority replaces all subsisting authorities previously granted to the directors for the purposes of section 551 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered or agreed to be made under such authorities.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Special Resolution: Subject to the passing of resolution 6 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 6, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' pre-emption rights) did not apply to any such allotment or sale, provided that this power is limited to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of pounds10,904,831, provided that: (A) (unless previously revoked, varied or renewed by the Company) this power will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this power expires, make offers or agreements which would or might require equity securities to be allotted and/or treasury shares to be sold after its expiry and the directors may allot equity securities and/or sell treasury shares pursuant to such offers or agreement as if this power had not expired; and (B) this power replaces (except for any power conferred by resolution 6) all subsisting powers previously granted to the directors for the purposes of section 570 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect, without prejudice to any allotment of equity securities already made, offered or agreed to be made under such powers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CAPITAL STRUCTURE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To approve, on an advisory basis, the United Kingdom (&quot;UK&quot;) directors' remuneration report in the form set out in the Company's UK annual report (the &quot;UK Annual Report&quot;) for the period ended December 31, 2024.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To approve the directors' remuneration policy contained in the directors' remuneration report as set forth in the UK Annual Report for the period ended December 31, 2024.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2024, together with the reports of the directors and auditors thereon.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England (&quot;PwC-UK&quot;), as the Company's UK statutory auditor for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>LivaNova Plc</issuerName>
    <cusip>G5509L101</cusip>
    <isin>GB00BYMT0J19</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>176147.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>176147.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Universal Health Realty Income Trust</issuerName>
    <cusip>91359E105</cusip>
    <isin>US91359E1055</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of Trustees: Michael Allan Domb</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3075.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>3075.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Universal Health Realty Income Trust</issuerName>
    <cusip>91359E105</cusip>
    <isin>US91359E1055</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of Trustees: James P. Morey</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3075.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>3075.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Universal Health Realty Income Trust</issuerName>
    <cusip>91359E105</cusip>
    <isin>US91359E1055</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Election of Trustees: Rebecca A. Guzman</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3075.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>3075.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Universal Health Realty Income Trust</issuerName>
    <cusip>91359E105</cusip>
    <isin>US91359E1055</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Advisory (nonbinding) vote to approve named executive officer compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3075.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>3075.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Universal Health Realty Income Trust</issuerName>
    <cusip>91359E105</cusip>
    <isin>US91359E1055</isin>
    <meetingDate>06/11/2025</meetingDate>
    <voteDescription>Proposal to ratify the selection of KPMG, LLP as the Trust's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>3075.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>3075.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Michael Barber</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Paul Clancy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Daniel Levangie</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Kevin Conroy</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Shacey Petrovic</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Kimberly Popovits</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Katherine Zanotti</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of our named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To approve the 2025 Omnibus Long-Term Incentive Plan.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To approve an Amendment to the 2010 Employee Stock Purchase Plan to add 4,000,000 shares of stock to the pool of shares available for purchase by employees.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>COMPENSATION</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Exact Sciences Corporation</issuerName>
    <cusip>30063P105</cusip>
    <isin>US30063P1057</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>To vote on a shareholder proposal concerning the adoption of a director election resignation governance policy, if properly presented.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>SECURITY HOLDER</voteSource>
    <sharesVoted>115032.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>115032.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Directors: Craig A. Barbarosh</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Directors: Katie Cusack</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Directors: Michael J. Foster</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Directors: Lynne S. Katzmann</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Directors: Ann Kono</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Directors: Jeffrey A. Malehorn</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Election of Directors: Richard K. Matros</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Sabra Health Care REIT, Inc.</issuerName>
    <cusip>78573L106</cusip>
    <isin>US78573L1061</isin>
    <meetingDate>06/12/2025</meetingDate>
    <voteDescription>Approval, on an advisory basis, of the compensation of Sabra's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>626862.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>626862.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Election of Directors: Bonnie L. Bassler, Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Election of Directors: Michael S. Brown, M.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Election of Directors: Leonard S. Schleifer, M.D., Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Election of Directors: George D. Yancopoulos, M.D., Ph.D.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Proposal to approve, on an advisory basis, executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SHAREHOLDER RIGHTS AND DEFENSES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of Incorporation</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Regeneron Pharmaceuticals, Inc.</issuerName>
    <cusip>75886F107</cusip>
    <isin>US75886F1075</isin>
    <meetingDate>06/13/2025</meetingDate>
    <voteDescription>Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article VI of the Certificate of Incorporation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>CORPORATE GOVERNANCE</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>22826.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>22826.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARS Pharmaceuticals, Inc.</issuerName>
    <cusip>82835W108</cusip>
    <isin>US82835W1080</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Richard Lowenthal</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>466675.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>466675.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARS Pharmaceuticals, Inc.</issuerName>
    <cusip>82835W108</cusip>
    <isin>US82835W1080</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Peter Kolchinsky</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>466675.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>466675.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARS Pharmaceuticals, Inc.</issuerName>
    <cusip>82835W108</cusip>
    <isin>US82835W1080</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Brenton L. Saunders</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>466675.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>466675.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARS Pharmaceuticals, Inc.</issuerName>
    <cusip>82835W108</cusip>
    <isin>US82835W1080</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Peter A. Thompson</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>DIRECTOR ELECTIONS</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>466675.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>WITHHOLD</howVoted>
        <sharesVoted>466675.000000</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>ARS Pharmaceuticals, Inc.</issuerName>
    <cusip>82835W108</cusip>
    <isin>US82835W1080</isin>
    <meetingDate>06/25/2025</meetingDate>
    <voteDescription>To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>AUDIT-RELATED</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>466675.000000</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>466675.000000</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
</proxyVoteTable>
